DNMT1, a well‐documented oncoprotein, is essential for maintaining DNA methylation patterns during carcinogenesis, and plays important roles in tumor cell growth, and serves as a potential therapeutic target in several human cancers including HCC.29, 30, 31. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.